Moritz von Scheidt 

  •                                 
    Extbase Variable Dump
    'distribution:BiomSpeaker.html' (29 chars)
    
                            
  •                                     
    Extbase Variable Dump
    'fileadmin/Webdata/digimed/Fotos_Symposium_2021/DHM_von_Scheidt_300x300.jpg' (74 chars)
    
                                
  •                                     
    Extbase Variable Dump
    'Dr. med. Dr. med. univ. Moritz von Scheidt' (42 chars)
    
                                
  •                                     
    Extbase Variable Dump
    'Cardiologist and Internist, German Heart Center Munich|TUM University Hospit
     al - Deputy Scientific Management DigiMed Bayern    ' (124 chars)
    
                                
  •                                     
    Extbase Variable Dump
    'Moritz von Scheidt is a clinician scientist and cardiologist at the German H
     eart Center Munich of the Technical University of Munich. As a research fell
     ow at the University of California Los Angeles (UCLA) he studied atheroscler
     osis in genetically engineered mouse models in direct comparison to human co
     ronary artery disease supervised by Prof. Jake Lusis. He received an excelle
     nce grant from the German Centre of Cardiovascular Research (DZHK), third pa
     rty funding by the German Society of Cardiology (DGK) and the German Heart F
     oundation (Deutsche Herzstiftung e.V.). In 2021 he received a young investig
     ator award by the Leducq foundation and was awarded with the Uta and Jürgen 
     Breunig Research Price for the mechanistic identification of the transcripti
     on factor MAFF as an inflammatory dependent regulator of the LDL-receptor. I
     n 2022 he started his own Junior Research Group studying somatic mutations i
     n cardiovascular disease funded with 1.0 million Euro by the CORONA Foundati
     on. He is initiator and head of the MunIch CardiovaScular StudIes biObaNk (M
     ISSION) – one of the largest human cardiovascular tissue biobanks with acces
     s to human coronary samples. His research aim includes the translation from 
     genetics into functional biology, including the identification of biomarkers
      and potential treatment strategies.     ' (1329 chars)